RMD Open Podcast - BMJ Group

Podcast details

Technical and general information from the podcast's RSS feed.

Site

RSS

Apple

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

http://rmdopen.bmj.com/
2 shares
https://rmdopen.bmj.com/content/8/2/e002518.long
1 share
https://rmdopen.bmj.com/content/8/1/e002079
1 share

https://podcasts.apple.com/gb/podcast/rmd-open-rheumatic-and-musculoskeletal-diseases/id1237127864
2 shares

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

Publication history

Monthly episode publishing history over the past years.

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

Promoting gender equity in academic rheumatology

Episode 17

Tuesday, February 21, 2023 • Duration 29:04

In this podcast, Dr. Javier Rodríguez-Carrio talks to Dr. Pavel Ovseiko and Prof. Laura Coates about the recent paper on gender equity in academic rheumatology which emerged from a EULAR task force. They discuss the current situation of gender equity in academic rheumatology across Europe, the pros and cons of potential interventions to accelerate gender-equitable career advancement in this field and how and these be applied in the short- and long-term. Link to the viewpoint: https://rmdopen.bmj.com/content/8/2/e002518.long

Listen to more episodes of RMD Open: https://podcasts.apple.com/gb/podcast/rmd-open-rheumatic-and-musculoskeletal-diseases/id1237127864

Read moreCollapse

Autoantibodies against PTM proteins as biomarkers for lupus

Episode 16

Friday, January 13, 2023 • Duration 09:46

Autoantibodies against post-translationally modified proteins (PTM) are described in various rheumatic diseases and facilitate diagnosis and patient stratification. Researchers from the Leiden University Medical Center analysed the presence of autoantibodies against six different post-translational modifications in a cohort of patients with neuropsychiatric lupus. In this podcast, Leendert Trouw, Rory Monahan and Michelle van den Beukel discuss the results of their study with the ARD/RMDopen social media advisor Caroline Ospelt. Read the Open Access related paper: https://rmdopen.bmj.com/content/8/1/e002079

Listen to more episodes of RMD Open: https://podcasts.apple.com/gb/podcast/rmd-open-rheumatic-and-musculoskeletal-diseases/id1237127864

Read moreCollapse

Osteoarthritis or rheumatoid? The MDHAQ patient questionnaire role in routine rheumatology care

Episode 7

Tuesday, March 13, 2018 • Duration 06:08

Editor-in-Chief of RMD Open Bernard Combe is joined by Theodore Pincus, Rheumatologist at the Rush University, Chicago, to discuss how new screening tools such as the MDHAQ (Multidimensional Health Assessment Questionnaire) are improving diagnosis in rheumatology. To read more about these topics, visit the RMD Open website: MDHAQ/RAPID3 scores in patients with osteoarthritis are similar to or higher than in patients with rheumatoid arthritis: a cross-sectional study from current routine rheumatology care at four sites - http://rmdopen.bmj.com/content/3/1/e000391 Responsiveness of a simple RAPID-3-like index compared to disease-specific BASDAI and ASDAS indices in patients with axial spondyloarthritis - http://rmdopen.bmj.com/content/2/2/e000235 Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools - http://rmdopen.bmj.com/content/2/2/e000302

Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis - http://rmdopen.bmj.com/content/2/2/e000202.

Read moreCollapse

Sjögren’s syndrome: what do we know so far?

Episode 6

Thursday, January 25, 2018 • Duration 05:14

Professor Xavier Mariette (Head of Rheumatology at Université Paris-Sud, France) is an expert in Sjögren's syndrome. He tells Editor-in-Chief of RMD Open Bernard Combe what is known so far about a relatively unstudied autoimmune disease characterised by dryness of the mouth and eyes which is closely linked to rheumatoid arthritis and lupus. Read more about this subject on the RMD Open website: •“Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort” -http://rmdopen.bmj.com/content/2/1/e000179; •“SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome” - http://rmdopen.bmj.com/content/2/2/e000292;

•“Patient burden of Sjögren’s: a comprehensive literature review revealing the range and heterogeneity of measures used in assessments of severity” - http://rmdopen.bmj.com/content/3/2/e000443.

Read moreCollapse

Rheumatic immune-related adverse events of checkpoint therapy for cancer

Episode 5

Wednesday, December 6, 2017 • Duration 05:56

Cassandra Calabrese (Cleveland Clinic Foundation, Ohio, USA) speaks with Editor-in-Chief of RMD Open Bernard Combe about checkpoint inhibitors. For more information, please visit the RMD Open website, where the related article to this podcast can also be found:

Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity: http://rmdopen.bmj.com/content/3/1/e000412.

Read moreCollapse

Branded drug or biosimilar? Reasons to adopt generics in rheumatology, by Professor Jonathan Kay

Episode 4

Monday, November 6, 2017 • Duration 05:17

Professor Jonathan Kay (Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School and UMass Memorial Medical Center, Worcester, Massachusetts, USA) tells Editor-in-Chief of RMD Open Bernard Combe why he supports the switch from branded drugs to their cheaper biosimilar. They spoke at the EULAR conference 2017, held in Madrid, in June. For more information on this topic read: • Key design considerations on comparative clinical efficacy studies for biosimilars: adalimumab as an example - http://rmdopen.bmj.com/content/2/1/e000154 • Biosimilars: what do patients need to consider? - http://rmdopen.bmj.com/content/1/1/e000141 • Biosimilars in rheumatology: what the clinician should know - http://rmdopen.bmj.com/content/1/1/e000010

• Switching from originator biological agents to biosimilars: what is the evidence and what are the issues? - http://rmdopen.bmj.com/content/3/2/e000492.

Read moreCollapse

Early diagnosis and treatment: the Rheumatic Diseases Portuguese Register

Episode 3

Monday, July 17, 2017 • Duration 05:39

Dr Joao Fonseca, head of the Rheumatology Department at the Lisbon Academic Medical Centre (Faculdade de Medicina da Universidade de Lisboa), tells Editor in Chief of RMD Open Bernard Combe how the data from the reuma.pt database is improving the early diagnosis and treatment of arthritis in Portugal. The Rheumatic Diseases Portuguese Register (Reuma.pt) was started by the Portuguese Society of Rheumatology in 2008 with the aim to register patients suffering from all the different inflammatory joint diseases.

http://rmdopen.bmj.com/

Read moreCollapse

Interleukin-17: a role in inflammatory arthritis and implication for clinical practice

Episode 2

Friday, May 5, 2017 • Duration 13:34

Interleukin-17 (IL-17A) is a cytokine critical for the acute defence against extracellular bacterial and fungal infections. Excess production during chronic inflammation has been associated with many inflammatory and autoimmune disorders. In this podcast, the Editor-in-Chief of RMD Open Bernard Combe and Pierre Miossec (Department of Immunology and Rheumatology, University of Lyon, France) discuss a review paper about an update on IL-17A. The review concludes that the use of IL-17 inhibition in psoriatic arthritis (PsA) is easy to understand because of the role of IL-17 in bone destruction. However, the use of the same inhibitors for the treatment of ankylosing spondylitis (AS) implies another understanding. In fact, IL-17 specifically in combination with TNF, induces bone matrix formation by isolated osteoblasts. This is the case at the site of ligaments insertion, where osteoclasts are absent. Local bone formation leads to syndesmophytes. Professor Miossec also explains how these findings might impact clinical practice.

For more details about this article, visit the RMD Open website: http://rmdopen.bmj.com/content/3/1/e000284.

Read moreCollapse

Welcome to RMD Open

Episode 1

Wednesday, February 4, 2015 • Duration 05:39

BMJ and EULAR are launching a new rheumatic and musculoskeletal diseases journal, RMD Open, and Editor-in-Chief Bernard Combe explains what readers and authors can look forward to.

http://rmdopen.bmj.com/

Read moreCollapse

Balancing risks with JAK inhibitors in RMDs after the ORAL Surveillance study

Episode 15

Friday, July 15, 2022 • Duration 17:10

In this podcast, Dr. Javier Rodríguez-Carrio (1) talks to Dr. Tue Kragstrup (2) about the recent safety data on JAK inhibitors emerged after the ORAL Surveillance study. They discuss what is the current situation, the potential strategies to escape a ‘static’ situation, by managing uncertainty in the context of balancing risks, patient preferences and shared-decision process. Read the Open Access related paper: https://rmdopen.bmj.com/content/8/1/e002236

(1) Javier Rodríguez-Carrio (University of Oviedo) (@javierrcarrio); (2) Tue Wenzel Kragstrup (University of Aarhus) (@KragstrupTW)

Read moreCollapse

RMD Open Podcast – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

RMD Open Podcast – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

Other25

Apple Podcast1

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Related Shows Based on Content Similarities

Other25

Apple Podcast1